Literature DB >> 10098729

Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer.

N Benachenhou1, S Guiral, I Gorska-Flipot, D Labuda, D Sinnett.   

Abstract

To study the involvement of DNA mismatch-repair genes in sporadic breast cancer, matched normal and tumoral DNA samples of 22 patients were analysed for genetic instability and loss of heterozygosity (LOH) with 42 microsatellites at or linked to hMLH1 (3p21), hMSH2 (2p16), hMSH3 (5q11-q13), hMSH6 (2p16), hPMS1 (2q32) and hPMS2 (7p22) loci. Chromosomal regions 3p21 and 5q11-q13 were found hemizygously deleted in 46% and 23% of patients respectively. Half of the patients deleted at hMLH1 were also deleted at hMSH3. The shortest regions of overlapping (SRO) deletions were delimited by markers D3S1298 and D3S1266 at 3p21 and by D5S647 and D5S418 at 5q11-q13. Currently, the genes hMLH1 (3p21) and hMSH3 (5q11-q13) are the only known candidates located within these regions. The consequence of these allelic losses is still unclear because none of the breast cancers examined displayed microsatellite instability, a hallmark of mismatch-repair defect during replication error correction. We suggest that hMLH1 and hMSH3 could be involved in breast tumorigenesis through cellular functions other than replication error correction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098729      PMCID: PMC2362257          DOI: 10.1038/sj.bjc.6690162

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  52 in total

1.  Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families.

Authors:  B Newman; M A Austin; M Lee; M C King
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Mismatch repair and recombination in E. coli.

Authors:  M Jones; R Wagner; M Radman
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

3.  High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.

Authors:  S Man; I O Ellis; M Sibbering; R W Blamey; J D Brook
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

4.  A second-generation YAC contig map of human chromosome 3.

Authors:  R M Gemmill; I Chumakov; P Scott; B Waggoner; P Rigault; J Cypser; Q Chen; J Weissenbach; K Gardiner; H Wang
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

5.  Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer.

Authors:  T G Paulson; F A Wright; B A Parker; V Russack; G M Wahl
Journal:  Cancer Res       Date:  1996-09-01       Impact factor: 12.701

6.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

7.  Chromosome 5 allele loss in human colorectal carcinomas.

Authors:  E Solomon; R Voss; V Hall; W F Bodmer; J R Jass; A J Jeffreys; F C Lucibello; I Patel; S H Rider
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

8.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

9.  Allele loss occurs frequently at hMLH1, but rarely at hMSH2, in sporadic colorectal cancers with microsatellite instability.

Authors:  I P Tomlinson; M Ilyas; W F Bodmer
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

10.  Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.

Authors:  M Tavassoli; H Steingrimsdottir; E Pierce; X Jiang; M Alagoz; F Farzaneh; I G Campbell
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

View more
  13 in total

1.  Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients.

Authors:  S Dasgupta; S B Chakraborty; A Roy; S Roychowdhury; C K Panda
Journal:  Mol Pathol       Date:  2003-10

2.  The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair.

Authors:  J M M van Oers; Y Edwards; R Chahwan; W Zhang; C Smith; X Pechuan; S Schaetzlein; B Jin; Y Wang; A Bergman; M D Scharff; W Edelmann
Journal:  Oncogene       Date:  2013-09-09       Impact factor: 9.867

3.  Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide.

Authors:  G Marra; S D'Atri; C Corti; L Bonmassar; M S Cattaruzza; P Schweizer; K Heinimann; Z Bartosova; M Nyström-Lahti; J Jiricny
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

4.  Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability.

Authors:  Jens Plaschke; Mark Preußler; Andreas Ziegler; Hans K Schackert
Journal:  Int J Colorectal Dis       Date:  2012-01-10       Impact factor: 2.571

5.  Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma.

Authors:  Abdel-Rahman N Zekri; Gelane M Sabry; Abeer A Bahnassy; Kamal A Shalaby; Sabrin A Abdel-Wahabh; Serag Zakaria
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

Review 6.  Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms.

Authors:  Bryan P Rowe; Peter M Glazer
Journal:  Breast Cancer Res       Date:  2010-04-30       Impact factor: 6.466

7.  Disruption of the pelota gene causes early embryonic lethality and defects in cell cycle progression.

Authors:  Ibrahim M Adham; Mahmoud A Sallam; Gerd Steding; Monika Korabiowska; Ulrich Brinck; Sigrid Hoyer-Fender; Changkyu Oh; Wolfgang Engel
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

8.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

9.  Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore.

Authors:  Hui-Ling Yap; Wei-Shieng Chieng; Jasmine Rui-Chen Lim; Robert Seng-Cheong Lim; Ross Soo; Jiayi Guo; Soo-Chin Lee
Journal:  Fam Cancer       Date:  2008-08-23       Impact factor: 2.375

Review 10.  Perspectives on the chemical etiology of breast cancer.

Authors:  Lillian S DeBruin; P David Josephy
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.